Medicaid MCOs Retain Formulary Flexibility Under Affordable Care Act
This article was originally published in The Pink Sheet Daily
Executive Summary
CMS clarifies that Medicaid drug rebate provisions under the Affordable Care Act should not be interpreted to mean that a state's Medicaid fee-for-service and managed care organizations must have the same formularies.
You may also be interested in...
CMS To Issue Guidance Interpreting Affordable Care Act's Effect On Medicaid Formularies
Confusion has arisen as to whether the health reform statute's changes to Medicaid drug rebates means that a state Medicaid program's fee-for-service and managed care organization formularies must be identical.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.